Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in...
Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
12 Jun 2020
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based thera...
Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
12 Jun 2020
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients wi...
Dr Sara Lonardi - Istituto Oncologico Veneto, Padua, Italy
11 Jun 2020
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/d...
Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris, Fran...
5 Jun 2020
Highlights from ASCO 2020
Dr Bishal Gyawali - Queen's University, Kingston, Canada
5 Jun 2020
An oncologist's experience of managing breast cancer during the COVID-19 outbrea...
Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy
28 Apr 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
22 Apr 2020
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast c...
Dr. Geraldo Alves - Hospital Santa Rosa, Brasil
26 Mar 2020
Enhancing curative resection for GI cancers; margins, nodes and recovery
Dr Robin Thambudorai- Tata Medical Center, Kolkata, India
6 Mar 2020
Neoadjuvant radiotherapy in rectal cancers
Prof Reena Engineer - Tata Medical Center, Kolkata, India
6 Mar 2020
Management of GI cancers: Burdens, outcomes, gaps
Dr Mohandas Mallath - Tata Medical Center, Kolkata, India
6 Mar 2020
Role of adjuvant and neoadjuvant therapy in colorectal cancer
Prof Atul Sharma - All India Institute of Medical Science, Delhi, India
6 Mar 2020
